Structural requirements at the N-terminus of urotensin II octapeptides.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Peptides

• Publication date

  2002-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0196-9781(02)00266-8PMID 12535707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.

  2002cited by this paper
• Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.

  2001cited by this paper
• Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

  2001cited by this paper
• Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1

  2000cited by this paper
• Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Highly potent cyclic disulfide antagonists of somatostatin.

  1999cited by this paper
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Potent antagonists of somatostatin: synthesis and biology.

  1998cited by this paper
• Complex effects of Gillichthys urotensin II on rat aortic strips

  1987cited by this paper
• Contraction of major artery segments of rat by fish neuropeptide urotensin II.

  1987cited by this paper
• SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

  1982cited by this paper

• Urotensin receptor in GtoPdb v.2021.3

  2021cites this paper
• Urotensin receptor (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.

  2016cites this paper
• NMR spectroscopy: a useful tool for drugs development and monitoring biological reactions

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015cites this paper
• Effect of Different Peptides

  2015cites this paper
• Urotensin‐II receptor is over‐expressed in colon cancer cell lines and in colon carcinoma in humans

  2014cites this paper
• Urantide Conformation and Interaction with the Urotensin‐II Receptor

  2014cites this paper
• Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.

  2014cites this paper
• New insight into the binding mode of peptides at urotensin‐II receptor by Trp‐constrained analogues of P5U and urantide

  2013cites this paper
• Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures

  2013cites this paper
• Ligand-Supported Purification of the Urotensin-II Receptor

  2010cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Ligand supported purification of the Urotensin-II receptor

  2010cites this paper
• Involvement of Novel Cardiac Peptides in Healthy and Ischemic Hearts

  2009influential citation
• New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.

  2009cites this paper
• Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5.

  2008cites this paper
• Role of urotensin II in atherosclerotic cardiovascular diseases.

  2008cites this paper
• Neuropeptide interactions and REM sleep: a role for Urotensin II?

  2008cites this paper
• Structure-activity relationships of urotensin II and URP.

  2008cites this paper
• Structure–activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11)

  2008cites this paper
• Cardiovascular Activity

  2008cites this paper
• Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.

  2006cites this paper
• Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts.

  2006cites this paper
• Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity

  2006cites this paper
• Isochromanone-based urotensin-II receptor agonists.

  2005cites this paper
• From heart to mind

  2005cites this paper
• From heart to mind. The urotensin II system and its evolving neurophysiological role.

  2005cites this paper
• Effects of peptides, with emphasis on feeding, pain, and behavior

  2004cites this paper
• Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.

  2004cites this paper
• Effects of peptides, with emphasis on feeding, pain, and behavior A 5-year (1999-2003) review of publications in Peptides.

  2004cites this paper
• Urotensin‐II receptor peptide agonists

  2004cites this paper
• Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines

  2004cites this paper
• From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function.

  2004cites this paper
• Chapter 11. Urotensin-II receptor modulators

  2003cites this paper